| 1 | 183320-29-8 | 厄洛替尼杂质 | CP 373413 | C21H21N3O4
| | |
| 2 | | AURORA 506 | AURORA 506 | C21H21N3O4
| | |
| 3 | 21929-66-8 | N-CBZ-BZL-组氨酸 | Z-HIS(BZL)-OH | C21H21N3O4
| | |
| 4 | 2101321-76-8 | Kv3 modulator 2 | Kv3 modulator 2 | C21H21N3O4
| | |
| 5 | 1623481-80-0 | ML381(VU0488130) | ML381(VU0488130) | C21H21N3O4
| | |
| 6 | 144085-32-5 | ANGIOTENSIN I-CONVERTING ENZYME (ACE) INACTIVATOR | CYANOAC-PHE-PHE-OH | C21H21N3O4
| | |
| 7 | 945859-89-2 | Fmoc-L-photo-methionine | Fmoc-L-photo-methionine | C21H21N3O4
| | |
| 8 | 29854-52-2 | 2-Nitrostrychnidin-10-one | 2-Nitrostrychnidin-10-one | C21H21N3O4
| | |
| 9 | 20794-07-4 | NA-CBZ-N-IM-BENZYL-L-HISTIDINE | NA-CBZ-N-IM-BENZYL-L-HISTIDINE | C21H21N3O4
| | |
| 10 | 183321-86-0 | OSI-420Free Base | OSI-420, Free Base (Desmethyl Erlotinib) | C21H21N3O4
| 杂质对照品;细胞生物学试剂;对照品-杂质对照品;小分子抑制剂，天然产物 | |
| 11 | 1216420-11-9 | OSI-420-d4, Free Base (Desmethyl Erlotinib-d4) | OSI-420-d4, Free Base (Desmethyl Erlotinib-d4) | C21H21N3O4
| | |
| 12 | 143632-16-0 | 1-(2-deoxyribofuranosyl)-4-(3-benzamido)phenylimidazole | 1-(2-deoxyribofuranosyl)-4-(3-benzamido)phenylimidazole | C21H21N3O4
| | |
| 13 | | 4-[(1-benzyl-4-piperidinyl)amino]-3-nitro-2H-chromen-2-one | 4-[(1-benzyl-4-piperidinyl)amino]-3-nitro-2H-chromen-2-one | C21H21N3O4
| | |
| 14 | 929836-38-4 | N-{2-[(3,4-dimethoxybenzoyl)amino]ethyl}-2-quinolinecarboxamide | N-{2-[(3,4-dimethoxybenzoyl)amino]ethyl}-2-quinolinecarboxamide | C21H21N3O4
| | |
| 15 | | N-(2-METHYLBENZYL)-2-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)OXY]BENZAMIDE | N-(2-METHYLBENZYL)-2-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)OXY]BENZAMIDE | C21H21N3O4
| | |
| 16 | | 2,5-Dimethoxybenzoic acid 2-[(3,4'-bipyridin-6-yl)amino]ethyl ester | 2,5-Dimethoxybenzoic acid 2-[(3,4'-bipyridin-6-yl)amino]ethyl ester | C21H21N3O4
| | |
| 17 | | N-[(S)-ALPHA-METHYLBENZYL]-2-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)OXY]BENZAMIDE | N-[(S)-ALPHA-METHYLBENZYL]-2-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)OXY]BENZAMIDE | C21H21N3O4
| | |
| 18 | 185298-58-2 | hnps-PLA Inhibitor | 2-(4-(2-amino-2-oxoethoxy)-1-benzyl-2-ethyl-1H-indol-3-yl)-2-oxoacetamide | C21H21N3O4
| | |
| 19 | | 2-(acetylamino)-N-(1,3-benzodioxol-5-ylmethyl)-3-(1H-indol-3-yl)propanamide | 2-(acetylamino)-N-(1,3-benzodioxol-5-ylmethyl)-3-(1H-indol-3-yl)propanamide | C21H21N3O4
| | |
| 20 | | 6-[N-(3,4,5-Trimethoxyphenyl)-N-(2-propynyl)aminomethyl]quinazolin-4(3H)-one | 6-[N-(3,4,5-Trimethoxyphenyl)-N-(2-propynyl)aminomethyl]quinazolin-4(3H)-one | C21H21N3O4
| | |
| 21 | 93857-34-2 | 5-oxo-L-proline, compound with 2-methyl-3-(o-tolyl)quinazolin-4(3H)-one (1:1) | 5-oxo-L-proline, compound with 2-methyl-3-(o-tolyl)quinazolin-4(3H)-one (1:1) | C21H21N3O4
| | |
| 22 | 325831-50-3 | 2-{[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]amino}-N,N-diethylbenzamide | 2-{[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]amino}-N,N-diethylbenzamide | C21H21N3O4
| | |
| 23 | 312615-90-0 | 3-{4-nitrophenyl}-7-methoxy-2-propionyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole | 3-{4-nitrophenyl}-7-methoxy-2-propionyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole | C21H21N3O4
| | |
| 24 | 353252-99-0 | 4-hydroxy-2-oxo-N'-(phenylacetyl)-1-propyl-1,2-dihydro-3-quinolinecarbohydrazide | 4-hydroxy-2-oxo-N'-(phenylacetyl)-1-propyl-1,2-dihydro-3-quinolinecarbohydrazide | C21H21N3O4
| | |
| 25 | | 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[4-(4-morpholinyl)phenyl]propanamide | 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[4-(4-morpholinyl)phenyl]propanamide | C21H21N3O4
| | |
| 26 | 371227-21-3 | 4-hydroxy-N'-(4-methylbenzoyl)-2-oxo-1-propyl-1,2-dihydro-3-quinolinecarbohydrazide | 4-hydroxy-N'-(4-methylbenzoyl)-2-oxo-1-propyl-1,2-dihydro-3-quinolinecarbohydrazide | C21H21N3O4
| | |
| 27 | 606946-80-9 | 5-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-2-(phenoxymethyl)-1,3-oxazole-4-carbonitrile | 5-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-2-(phenoxymethyl)-1,3-oxazole-4-carbonitrile | C21H21N3O4
| | |
| 28 | | 4-(3,4-DIMETHOXYPHENYL)-3-(4-ETHOXYPHENYL)-4,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-6(1H)-ONE | 4-(3,4-DIMETHOXYPHENYL)-3-(4-ETHOXYPHENYL)-4,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-6(1H)-ONE | C21H21N3O4
| | |
| 29 | | (5E)-5-[1-(BENZYLAMINO)ETHYLIDENE]-1-(2-ETHOXYPHENYL)PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE | (5E)-5-[1-(BENZYLAMINO)ETHYLIDENE]-1-(2-ETHOXYPHENYL)PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE | C21H21N3O4
| | |
| 30 | 904816-43-9 | 1-(2-BENZO[1,3]DIOXOL-5-YL-IMIDAZO[1,2-A]PYRIDIN-3-YLMETHYL)-PIPERIDINE-3-CARBOXYLIC ACID | 1-(2-BENZO[1,3]DIOXOL-5-YL-IMIDAZO[1,2-A]PYRIDIN-3-YLMETHYL)-PIPERIDINE-3-CARBOXYLIC ACID | C21H21N3O4
| | |
| 31 | | 4-(3-ETHOXY-4-HYDROXYPHENYL)-3-(4-ETHOXYPHENYL)-4,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-6(1H)-ONE | 4-(3-ETHOXY-4-HYDROXYPHENYL)-3-(4-ETHOXYPHENYL)-4,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-6(1H)-ONE | C21H21N3O4
| | |
| 32 | 606948-64-5 | 2-[(2-methoxyphenoxy)methyl]-5-{[2-(4-methoxyphenyl)ethyl]amino}-1,3-oxazole-4-carbonitrile | 2-[(2-methoxyphenoxy)methyl]-5-{[2-(4-methoxyphenyl)ethyl]amino}-1,3-oxazole-4-carbonitrile | C21H21N3O4
| | |
| 33 | 1251695-06-3 | N-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-methyl-4-oxo-1-propyl-1,8-naphthyridine-3-carboxamide | N-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-methyl-4-oxo-1-propyl-1,8-naphthyridine-3-carboxamide | C21H21N3O4
| | |
| 34 | 1374510-93-6 | 2-[(E)-2-(二甲基氨基)乙烯基]-6-(4-甲氧苯基)-5-氧代-5,6-二氢-(口+奈)啶-3-甲酸甲酯 | Methyl 2-[(E)-2-(dimethylamino)vinyl]-6-(4-methoxyphenyl)-5-oxo-5,6-dihydro-1,6-naphthyridine-3-c | C21H21N3O4
| | |
| 35 | 1007689-79-3 | Furo[2,3-d]pyrimidine-2,4(1H,3H)-dione, 6-[(2-methoxyethyl)amino]-1,3-dimethyl-5-(1-naphthalenyl)- | Furo[2,3-d]pyrimidine-2,4(1H,3H)-dione, 6-[(2-methoxyethyl)amino]-1,3-dimethyl-5-(1-naphthalenyl)- | C21H21N3O4
| | |
| 36 | 879936-87-5 | 3-(2-hydroxyphenyl)-4-(3-hydroxyphenyl)-5-(3-methoxypropyl)-4,5-dihydropyrrolo[3,4-c]pyrazol-6(2H)-one | 3-(2-hydroxyphenyl)-4-(3-hydroxyphenyl)-5-(3-methoxypropyl)-4,5-dihydropyrrolo[3,4-c]pyrazol-6(2H)-one | C21H21N3O4
| | |
| 37 | 473725-26-7 | Benzamide, 3-[[3,4-dioxo-2-[[(1S)-1-phenylethyl]amino]-1-cyclobuten-1-yl]amino]-2-hydroxy-N,N-dimethyl- | Benzamide, 3-[[3,4-dioxo-2-[[(1S)-1-phenylethyl]amino]-1-cyclobuten-1-yl]amino]-2-hydroxy-N,N-dimethyl- | C21H21N3O4
| | |
| 38 | 907556-79-0 | 3-Furancarboxylic acid, 4,5-dihydro-4-[(phenylacetyl)hydrazono]-2-(phenylamino)-, ethyl ester (9CI) | 3-Furancarboxylic acid, 4,5-dihydro-4-[(phenylacetyl)hydrazono]-2-(phenylamino)-, ethyl ester (9CI) | C21H21N3O4
| | |
| 39 | 2640506-74-5 | 非奈利酮杂质01 | 1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-, (4S)- | C21H21N3O4
| 217- 非奈利酮 | |
| 40 | 354997-18-5 | 2-(2-methoxy-4-{[3-methyl-1-(4-methylphenyl)-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]methyl}phenoxy)acetamide | 2-(2-methoxy-4-{[3-methyl-1-(4-methylphenyl)-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]methyl}phenoxy)acetamide | C21H21N3O4
| | |
| 41 | 339062-37-2 | 4 H -1-Benzopyran-3-carbonitrile, 2-amino-7-(ethylamino)-4-(7-methoxy-1,3-benzodioxol-5-yl)-6-methyl- (9CI, ACI) | 4 H -1-Benzopyran-3-carbonitrile, 2-amino-7-(ethylamino)-4-(7-methoxy-1,3-benzodioxol-5-yl)-6-methyl- (9CI, ACI) | C21H21N3O4
| | |
| 42 | | 2,10-Diaza-9-(4-hydroxy-3-nitrophenyl)-5,5-dimethyltricyclo[9.4.0.0<3,8>]pentadeca-1(11),3(8),12,14-tetraen-7-one | 2,10-Diaza-9-(4-hydroxy-3-nitrophenyl)-5,5-dimethyltricyclo[9.4.0.0<3,8>]pentadeca-1(11),3(8),12,14-tetraen-7-one | C21H21N3O4
| | |